(Q79373089)

English

Decitabine

scientific article published on 01 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Decitabine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Peter Kirkpatrick

3

object named as

Peter Kirkpatrick

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Steven D Gore

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Carole Jones

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Nature Reviews Drug Discovery

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

891-892

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

https://scigraph.springernature.com/pub.10.1038/nrd2180

0 references

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Methylation inhibitor therapy in the treatment of myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

DNA methylation and gene silencing in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Cellular differentiation, cytidine analogs and DNA methylation

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Efficacy of lenalidomide in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRD2180

31 March 2020

Identifiers

10.1038/NRD2180

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17117522%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79373089&oldid=1988141495"